BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Rojas M, Chávez-Castillo M, Bautista J, Ortega Á, Nava M, Salazar J, Díaz-Camargo E, Medina O, Rojas-Quintero J, Bermúdez V. Alzheimer’s disease and type 2 diabetes mellitus: Pathophysiologic and pharmacotherapeutics links. World J Diabetes 2021; 12(6): 745-766 [PMID: 34168725 DOI: 10.4239/wjd.v12.i6.745]
URL: https://www.wjgnet.com/1948-9358/full/v12/i6/745.htm
Number Citing Articles
1
Geetika Nehra, Bjoern Bauer, Anika M.S. Hartz. Blood-brain barrier leakage in Alzheimer’s disease: From discovery to clinical relevancePharmacology & Therapeutics 2022; 234: 108119 doi: 10.1016/j.pharmthera.2022.108119
2
Teresa Vezza, Víctor M Víctor. SIRT1 and miR-34a-5p: Valuable Biomarkers for the Early Detection of Cognitive Impairment in Type 2 Diabetes MellitusThe Journal of Clinical Endocrinology & Metabolism 2024; 109(7): e1546 doi: 10.1210/clinem/dgad740
3
Cong Li, Haifeng Qian, Lina Feng, Mingquan Li. Causal Association Between Type 2 Diabetes Mellitus and Alzheimer’s Disease: A Two-Sample Mendelian Randomization StudyJournal of Alzheimer's Disease Reports 2024; 8(1): 945 doi: 10.3233/ADR-240053
4
Fan Zhang, Melissa Petersen, Leigh Johnson, James Hall, Sid E. O’Bryant. Comorbidities Incorporated to Improve Prediction for Prevalent Mild Cognitive Impairment and Alzheimer’s Disease in the HABS-HD StudyJournal of Alzheimer's Disease 2023; 96(4): 1529 doi: 10.3233/JAD-230755
5
Albert Joseph Sulangi, Sarah E Lyons, Amy A Abdou, Hemangi Patel, Deepika Nagliya, Eileen Joseph, Carmel Joseph, Divya Kumar, Shivani Patel, Isha Jinwala, Mayur S Parmar. Exploring the Therapeutic Potential of DPP4 Inhibitors in Alzheimer's Disease: Molecular Insight and Clinical OutcomeCureus 2024;  doi: 10.7759/cureus.72648
6
Ides M Colin, Lidia W Szczepanski, Anne-Catherine Gérard, Jose-Antonio Elosegi. Emerging Evidence for the Use of Antidiabetic Drugs, Glucagon-like Peptide 1 Receptor Agonists, for the Treatment of Alzheimer’s DiseaseEuropean Endocrinology 2023; 19(1): 16 doi: 10.17925/EE.2023.19.1.16
7
Mateusz Kciuk, Weronika Kruczkowska, Julia Gałęziewska, Katarzyna Wanke, Żaneta Kałuzińska-Kołat, Marta Aleksandrowicz, Renata Kontek. Alzheimer’s Disease as Type 3 Diabetes: Understanding the Link and ImplicationsInternational Journal of Molecular Sciences 2024; 25(22): 11955 doi: 10.3390/ijms252211955
8
Keke Song, Rongrong Zhang, Xiaoqi Zhao, Lan Yang, Qiang Wang, Wei Gao. Perioperative neurocognitive disorder changes in elderly diabetes patients within 30 days after surgery: a retrospective cohort studyAging Clinical and Experimental Research 2023; 35(12): 2911 doi: 10.1007/s40520-023-02583-9
9
Khaled Hameed Husain, Saud Faisal Sarhan, Haya Khaled Ali Abdulla AlKhalifa, Asal Buhasan, Abu Saleh Md Moin, Alexandra E. Butler. Dementia in Diabetes: The Role of HypoglycemiaInternational Journal of Molecular Sciences 2023; 24(12): 9846 doi: 10.3390/ijms24129846
10
Tatiana Korolenko, Nina Dubrovina, Marina Ovsyukova, Nataliya Bgatova, Michael Tenditnik, Alexander Pupyshev, Anna Akopyan, Natalya Goncharova, Chih-Li Lin, Evgeny Zavjalov, Maria Tikhonova, Tamara Amstislavskaya. Treatment with Autophagy Inducer Trehalose Alleviates Memory and Behavioral Impairments and Neuroinflammatory Brain Processes in db/db MiceCells 2021; 10(10): 2557 doi: 10.3390/cells10102557
11
Haiyang Du, Xiaoyu Meng, Yu Yao, Jun Xu. The mechanism and efficacy of GLP-1 receptor agonists in the treatment of Alzheimer’s diseaseFrontiers in Endocrinology 2022; 13 doi: 10.3389/fendo.2022.1033479
12
Kayalvizhi Rajendran, Uma Maheswari Krishnan. Mechanistic insights and emerging therapeutic stratagems for Alzheimer’s diseaseAgeing Research Reviews 2024; 97: 102309 doi: 10.1016/j.arr.2024.102309
13
Jiwei Jiang, Hanping Shi, Shirui Jiang, Anxin Wang, Xinying Zou, Yanli Wang, Wenyi Li, Yuan Zhang, Mengfan Sun, Qiwei Ren, Jun Xu. Nutrition in Alzheimer’s disease: a review of an underappreciated pathophysiological mechanismScience China Life Sciences 2023; 66(10): 2257 doi: 10.1007/s11427-022-2276-6
14
Rima Pramanik, Anuradha Dey, Anirban Kr Chakrabarty, Dipankar Banerjee, Avinash Narwaria, Swapnil Sharma, Rajiva Kumar Rai, Chandra Kant Katiyar, Sunil Kumar Dubey. Diabetes mellitus and Alzheimer's disease: Understanding disease mechanisms, their correlation, and promising dual activity of selected herbsJournal of Ethnopharmacology 2024; 333: 118402 doi: 10.1016/j.jep.2024.118402
15
Richard Simon Machado, Khiany Mathias, Larissa Joaquim, Rafaella Willig de Quadros, Fabricia Petronilho, Gislaine Tezza Rezin. From diabetic hyperglycemia to cerebrovascular Damage: A narrative reviewBrain Research 2023; 1821: 148611 doi: 10.1016/j.brainres.2023.148611
16
Nagwa M. Abdelazeem, Wael M. Aboulthana, Ashraf S. Hassan, Abdulrahman A. Almehizia, Ahmed M. Naglah, Hamad M. Alkahtani. Synthesis, in silico ADMET prediction analysis, and pharmacological evaluation of sulfonamide derivatives tethered with pyrazole or pyridine as anti-diabetic and anti-Alzheimer's agentsSaudi Pharmaceutical Journal 2024; 32(5): 102025 doi: 10.1016/j.jsps.2024.102025
17
Elizabeth M. Rhea, Manon Leclerc, Hussein N. Yassine, Ana W. Capuano, Han Tong, Vladislav A. Petyuk, Shannon L. Macauley, Xavier Fioramonti, Owen Carmichael, Frederic Calon, Zoe Arvanitakis. State of the Science on Brain Insulin Resistance and Cognitive Decline Due to Alzheimer’s DiseaseAging and disease 2023; : 0 doi: 10.14336/AD.2023.0814
18
Hoda M. Moghazy, Nesreen G Abdelhaliem, Sherine Ahmed Mohammed, Asmaa Hassan, Amany Abdelrahman. Liraglutide versus pramlintide in protecting against cognitive function impairment through affecting PI3K/AKT/GSK-3β/TTBK1 pathway and decreasing Tau hyperphosphorylation in high-fat diet- streptozocin rat modelPflügers Archiv - European Journal of Physiology 2024; 476(5): 779 doi: 10.1007/s00424-024-02933-0
19
Toshiyuki Oshitari. Advanced Glycation End-Products and Diabetic Neuropathy of the RetinaInternational Journal of Molecular Sciences 2023; 24(3): 2927 doi: 10.3390/ijms24032927
20
Xin Yuan, Fei Yan, Li‐Hui Gao, Qian‐Hui Ma, Ju Wang. Hypericin as a potential drug for treating Alzheimer's disease and type 2 diabetes with a view to drug repositioningCNS Neuroscience & Therapeutics 2023; 29(11): 3307 doi: 10.1111/cns.14260
21
Asmaa Embaby Sewillam, Zahra M Hasan Sry, Naguib A Salem, Ayat Allah Farouk Ahmed Hussein, Ahmed Essmat, Heba Ahmed Ali Abdeen. Effect of structured physical therapy program on patients with diabetes and mild cognitive impairment: randomised controlled trialPhysiotherapy Quarterly 2024; 32(2): 100 doi: 10.5114/pq/166622
22
Guglielmina Froldi. View on Metformin: Antidiabetic and Pleiotropic Effects, Pharmacokinetics, Side Effects, and Sex-Related DifferencesPharmaceuticals 2024; 17(4): 478 doi: 10.3390/ph17040478
23
Keiko Shigemori, Sachiko Nomura, Tomohiro Umeda, Shuko Takeda, Takami Tomiyama. Peripheral Aβ acts as a negative modulator of insulin secretionProceedings of the National Academy of Sciences 2022; 119(12) doi: 10.1073/pnas.2117723119
24
Jessica E.B.F. Lima, Natalia C.S. Moreira, Elza T. Sakamoto-Hojo. Mechanisms underlying the pathophysiology of type 2 diabetes: From risk factors to oxidative stress, metabolic dysfunction, and hyperglycemiaMutation Research/Genetic Toxicology and Environmental Mutagenesis 2022; : 503437 doi: 10.1016/j.mrgentox.2021.503437
25
Enoc Mariano Cortés Malagón, Adolfo López Ornelas, Irlanda Olvera Gómez, José Bonilla Delgado. The Kynurenine Pathway, Aryl Hydrocarbon Receptor, and Alzheimer’s DiseaseBrain Sciences 2024; 14(9): 950 doi: 10.3390/brainsci14090950
26
Renshi Li, Fengjie Zheng, Peichen Xu, Li Lv, Yapeng Mu, Xianghua Zhuang, Shihong Chen. Correlation of mild cognitive impairment with the thickness of retinal nerve fiber layer and serum indicators in type 2 diabetic patientsFrontiers in Endocrinology 2024; 14 doi: 10.3389/fendo.2023.1299206
27
Flavia Agata Cimini, Marzia Perluigi, Ilaria Barchetta, Maria Gisella Cavallo, Eugenio Barone. Role of Biliverdin Reductase A in the Regulation of Insulin Signaling in Metabolic and Neurodegenerative Diseases: An UpdateInternational Journal of Molecular Sciences 2022; 23(10): 5574 doi: 10.3390/ijms23105574
28
Sophia Nazir. Salivary biomarkers: The early diagnosis of Alzheimer's diseaseAGING MEDICINE 2024; 7(2): 202 doi: 10.1002/agm2.12282
29
Ting Li, Hong-xia Cao, Dan Ke. Type 2 Diabetes Mellitus Easily Develops into Alzheimer’s Disease via Hyperglycemia and Insulin ResistanceCurrent Medical Science 2021; 41(6): 1165 doi: 10.1007/s11596-021-2467-2
30
Nathan R. Kerr, Chandler W. Mossman, Chih-Hsuan Chou, Joshua M. Bunten, Taylor J. Kelty, Thomas E. Childs, Randy Scott Rector, William David Arnold, Laurel A. Grisanti, Xiangwei Du, Frank W. Booth. Hindlimb immobilization induces insulin resistance and elevates mitochondrial ROS production in the hippocampus of female ratsJournal of Applied Physiology 2024; 137(3): 512 doi: 10.1152/japplphysiol.00234.2024
31
Anne Grosskopf, Jette Rahn, Ahyoung Kim, Gábor Szabó, Dan Rujescu, Frank Klawonn, Andrej Frolov, Andreas Simm. Peptide-Bound Glycative, AGE and Oxidative Modifications as Biomarkers for the Diagnosis of Alzheimer’s Disease—A Feasibility StudyBiomedicines 2024; 12(9): 2127 doi: 10.3390/biomedicines12092127
32
Sweta Priyadarshini Pradhan, Anindita Behera, Pratap Kumar Sahu. Effect of selenium nanoparticles conjugated Vildagliptin on cognitive dysfunction associated with Diabetes mellitusJournal of Drug Delivery Science and Technology 2024; 98: 105907 doi: 10.1016/j.jddst.2024.105907
33
Laryssa Alves-Borba, Verónica Espinosa-Fernández, Ania Canseco-Rodríguez, Ana María Sánchez-Pérez. ABA Supplementation Rescues IRS2 and BDNF mRNA Levels in a Triple-Transgenic Mice Model of Alzheimer’s DiseaseJournal of Alzheimer's Disease Reports 2023; 7(1): 1007 doi: 10.3233/ADR-230056
34
Yashika Arora, Anirban Dutta. Perspective: Disentangling the effects of tES on neurovascular unitFrontiers in Neurology 2023; 13 doi: 10.3389/fneur.2022.1038700
35
Norhamidar Ab-Hamid, Norsuhana Omar, Che Aishah Nazariah Ismail, Idris Long. Diabetes and cognitive decline: Challenges and future directionWorld Journal of Diabetes 2023; 14(6): 795-807 doi: 10.4239/wjd.v14.i6.795
36
Jiehui Chen, Yong Liu, Keru Zhou, Wei Zhang, Bin Wen, Kai Xu, Yazhou Liu, Ling Chen, Yue Huang, Benhong He, Weijian Hang, Juan Chen. DISC1 inhibits GSK3β activity to prevent tau hyperphosphorylation under diabetic encephalopathyBioFactors 2023; 49(1): 173 doi: 10.1002/biof.1884
37
Ozra Tabatabaei Malazy, Fatemeh Bandarian, Mostafa Qorbani, Shahrzad Mohseni, Somayeh Mirsadeghi, Maryam Peimani, Bagher Larijani. The effect of metformin on cognitive function: A systematic review and meta-analysisJournal of Psychopharmacology 2022; 36(6): 666 doi: 10.1177/02698811211057304
38
LaQuadria S. Robinson, Kristin D. Ashley, Tiffany Brown Ervin, Tina Smith, Loretta T. Lee. A Narrative Review of Alzheimer Dementia in African American and Hispanic Populations: The Health Care Provider's RoleThe Journal for Nurse Practitioners 2024; 20(8): 105104 doi: 10.1016/j.nurpra.2024.105104
39
Zheng Shen, Zheng-Yang Li, Meng-Ting Yu, Kai-Leng Tan, Si Chen. Metabolic perspective of astrocyte dysfunction in Alzheimer's disease and type 2 diabetes brainsBiomedicine & Pharmacotherapy 2023; 158: 114206 doi: 10.1016/j.biopha.2022.114206
40
Yanchun Li, Zhongyang Lu, Cameron L. Kirkwood, Keith L. Kirkwood, Stephen A. Wank, Ai‐Jun Li, Maria F. Lopes‐Virella, Yan Huang. GPR40 deficiency worsens metabolic syndrome‐associated periodontitis in miceJournal of Periodontal Research 2023; 58(3): 575 doi: 10.1111/jre.13107
41
Xian-wen Ye, Meng-nan Liu, Xuan Wang, Shui-qing Cheng, Chun-shuai Li, Yu-ying Bai, Lin-lin Yang, Xu-xing Wang, Jia Wen, Wen-juan Xu, Shu-yan Zhang, Xin-fang Xu, Xiang-ri Li. Exploring the common pathogenesis of Alzheimer’s disease and type 2 diabetes mellitus via microarray data analysisFrontiers in Aging Neuroscience 2023; 15 doi: 10.3389/fnagi.2023.1071391